Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that severe trauma can cause temporary hair loss, known as Telogen Effluvium, which usually resolves without treatment.

Amphetamines may not directly cause hair loss.

Hair loss after childbirth is more common in women who have had multiple births, cesarean deliveries, significant weight gain, and full-term pregnancies.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Hair loss can happen after severe H1N1 flu but usually grows back in 4 months.

Hair loss in women was often caused by stress, illness, childbirth, or low hemoglobin, with most cases being telogen effluvium.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Stress can cause temporary hair loss, which usually gets better after the stress is gone.

Scalp biopsy and digital phototrichogram help diagnose and manage different types of diffuse hair loss.

Most Iraqi women with telogen effluvium did not have a clear cause for their hair loss, and few had significant thinning.

Many women's hair loss is due to health issues, medication, nutrition, or stress.

The document's conclusion cannot be provided as it is not accessible for parsing.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

The author clarifies that alopecia areata incognito and diffuse alopecia areata are different types of hair loss with unique symptoms and challenges in diagnosis.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

People with Telogen Effluvium have similar zinc levels in their blood as healthy individuals.

The conclusion is that examining the scalp closely and checking for iron levels and thyroid issues is key to understanding chronic hair loss in women.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

A community dermatology event in Delhi showed a high need for follow-up and awareness about skin conditions.

A woman's hair loss was treated successfully with iron supplements for her iron deficiency.

Hair loss is a symptom of long COVID and can be treated with a protein-rich diet.

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

The paper concludes that detailed patient history, skin exams, and lab tests are crucial for diagnosing and treating hair loss from diffuse alopecia.

A six-year-old girl unusually had a hair loss condition common in middle-aged women.

A critically ill boy experienced hair loss likely due to the stress of his medical treatments, but his hair regrew completely in 1.5 months.

Most Iraqi women with telogen effluvium had no clear cause for their hair loss, and few had significant thinning.